EU lists rare nerve disorder as possible side-effect of AstraZeneca COVID-19 vaccine

FILE PHOTO: A medical worker holds a bottle of AstraZeneca’s COVID-19 vaccine at a vaccination centre in Kuala Lumpur, Malaysia May 5, 2021 in this file photo. REUTERS/Lim Huey Teng/File Photo/File Photo

(Reuters) – Europe’s medicines regulator has added a rare nerve-damaging disorder, Guillain-Barré syndrome, as a possible side-effect of AstraZeneca’s COVID-19 vaccine, regular safety updates from the watchdog showed on Wednesday.

The European Medicines Agency also tagged some other less severe side-effects to vaccines from Johnson & Johnson, Moderna as well as AstraZeneca’s shot.

Source: Read Full Article

Related posts:
  1. Fresh data show toll South African virus variant takes on vaccine efficacy
  2. Pfizer says South African variant could significantly reduce vaccine protection
  3. Teachers may play role in in-school COVID-19 transmission: U.S. CDC
  4. Israel freezes programme to send vaccines abroad, defence minister says
Health News Comments Off on EU lists rare nerve disorder as possible side-effect of AstraZeneca COVID-19 vaccine